CS Paper Radar

Is a 9B Decision Foundation Model Needed for Symptom-to-Disease Classification? Fine-Tuning Clef-Flash Against TF-IDF Baselines

S. M. Mahbub Uddin Ahmed

cs.CL cs.AI ·submitted 2026-10-10 16:13 UTC · v2
benchmarkcode/data

Abstract

Disease classification from patient-reported symptom descriptions is usually approached with lightweight discriminative models or with autoregressive large language models (LLMs), which understand language broadly but generate text token by token and require output parsing. We study decision foundation models, which score a closed set of candidate labels in a single forward pass without generating text. We adapt Clef-Flash, a 9-billion parameter decision model built on a Qwen3.5 backbone, to the 24-class Symptom2Disease benchmark using 4-bit quantized low-rank adaptation (QLoRA) on a stratified split of 960 training and 240 test cases. The fine-tuned model reaches 95.42% accuracy (95% CI 91.98-97.42%) and a macro F1 of 0.9551, up from 65.00% for the unadapted weights (62.92% through the remote API). However, TF-IDF linear SVM and logistic regression baselines trained on the same split reach 98.75% (95% CI 96.39-99.57%) with sub-millisecond CPU inference, so on this benchmark the fine-tuned model offers no accuracy advantage over a well-tuned linear classifier. A Leave-One-Symptom-Out clause-ablation analysis of four illustrative narratives shows predictions depending on distinguishing clauses: in a psoriasis example, removing the clause describing silvery scales lowers the predicted probability from above 99.99% to 0.12% and shifts the prediction to impetigo, while removing other clauses changes it by less than 0.001 percentage points. Decision architectures deliver structured, single-pass predictions from large language backbones, but short, lexically distinctive benchmarks such as Symptom2Disease cannot show an advantage over simple baselines; validation on longer, real clinical text and clinician review are needed.

Comment
v2: Corrected reported results against saved experiment outputs; added same-split TF-IDF baselines (which outperform the fine-tuned model); revised architecture description to match released code; removed unmeasured latency claims; new title. 20 pages, 5 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Multimodal Medical Image Parsing with Task-Specific Low-Rank Adapters

cs.CV cs.AIcs.LG ·2026-10-14 ·Taha Sabir, Alberto Montero Molina, Thinh Quang Ly, Veronika Dmitrenko, Mohammad Yaqub +1 more
code/data similarity 0.64
Abstract · 17 pages, 4 figures. FLARE 2026 Task 3 methodology paper (2D track)

Adapting a single vision-language model to medical image parsing requires training choices that reflect the demands of each task. We study task-specific adaptation with Qwen3.5-9B for FLARE 2026 Task 3, covering six task families and seven imaging modalities. Our system couples a shared, frozen 4-bit backbone with LoRA adapters selected from the input question. We customize adapter ranks and prompts, rebalance rare classification targets, and supplement regression training with dermatology classification examples. On the fixed internal holdout, the task-specific adapters achieve a dataset-macro balanced accuracy of 0.7791 for classification, a dataset-macro micro-F1 of 0.6286 for multi-label classification, a counting mean absolute error (MAE) of 11.73, a dataset-macro detection F1 of 0.8914, a dataset-macro regression MAE of 9.78, and a report-generation CRIMSON score of 0.8204. On the organizer's 1,703-example hidden-validation set, the submitted system achieves 0.8496 classification balanced accuracy, 0.5338 sample-averaged multi-label F1, and 14.5950 regression MAE. The final 30.1 GB container averages 3.1 seconds per case, including model loading, and produces identical outputs across repeated verification runs. The benefits vary across tasks, supporting the use of task-specific adapter configurations and image budgets within a shared medical vision-language model. Code is available at https://github.com/TahaSabir0/FLARE26-Hexapus.

0.27

Can decision models extract clinical data from cancer pathology reports? An evaluation of accuracy, calibration, and failure modes

cs.CL cs.AIcs.LG ·2026-11-15 ·Indranil Mallick, Paromita Roy
similarity 0.64
Abstract · 22 pages, 7 figures

Decision models are a new class of language model that, instead of generating text, choose one option per question from a fixed list and return a probability for every option. They have not yet been evaluated on clinical text. We evaluated two open-weights decision models, Nimble 9B and Tev1 4B, for extracting 25 fields from 1,113 oral cavity cancer pathology reports from a single centre, against a prospectively maintained clinical database. We compared them with two generative models: Qwen3.5 9B, run locally, and GLM-5.3-flash, run through a cloud API. Tev1 reached a mean field accuracy of 0.917 (95% CI 0.913 to 0.920), the same as Qwen3.5 9B (0.918; p = 0.26), and was four times faster (15 s against 61 s per report). Nimble reached 0.862 and GLM-5.3-flash 0.986. Both decision models matched GLM-5.3-flash on simple dichotomous categories. They were weak on measurements binned into categories, on fields whose correct answer was not reported, and on some complex decisions (e.g. involved margins). We found that the main cause of the inferior performance of Nimble's came from asking 25 questions in one request: with two questions per request, its accuracy improved. Pooled over fields, the returned probabilities were well calibrated (expected calibration error 0.022 and 0.026), but they did not flag systematic errors within single fields. A simulated strategy of sending answers with a probability below 0.94 to GLM-5.3-flash raised Tev1's accuracy to 0.982, with 38% of answers escalated. Decision models can extract explicitly stated findings from pathology reports quickly on local hardware and return useful probabilities. They should be validated in the configuration in which they will be used, restricted to the fields in which they are reliable, and combined with other methods for numeric values.

0.18

TrialJev: Open-Weight Single Pass Eligibility Scoring for Patient Trial Screening

cs.LG ·2026-11-06 ·Omar Ibrahim, Grant Hamblin, Benjamin Haibe-Kains
code/data similarity 0.64
Abstract · 38 pages. Code: https://github.com/oibrahi1/TrialJev. Models: https://huggingface.co/omareng/TrialJev

Clinical trial screening requires assessing large numbers of patient-trial pairs to prioritize candidates for detailed eligibility review, often under restrictions on sharing patient records. We introduce TrialJev, an open-weight eligibility scorer that uses LoRA-adapted Qwen models and a pointer head to score natural-language answer options in a single forward pass, without autoregressive decoding. Trained on TREC Clinical Trials 2021 and evaluated on 6,975 eligible-or-excluded pairs from 50 unseen TREC 2022 synthetic patients, TrialJev achieves 80.97% (Qwen3.5-27B) and 81.84% (Qwen3.8-27B) accuracy, compared with 79.87% and 79.93% for LLMs fine-tuned on the same data to generate verdicts. In matched batch-1 measurements, verdict generation takes 2.45-2.70 times as long as the one-pass inference of TrialJev at 9B-27B. Under a common development-fitted decision correction, the two 27B TrialJev models reach 80.99% and 81.88% accuracy, compared with 81.28% for the proprietary hosted Jev API; paired confidence intervals include zero. TrialJev runs locally on a single GPU, requiring approximately 178 ms per pair at 27B, without transmitting patient text to an external model API. An A/B-logit ablation shows that avoiding decoding, rather than the pointer head alone, accounts for the measured efficiency advantage. TrialJev is intended for first-pass prioritization of candidate trials, complementing rather than replacing explanatory models and clinical review. Evaluation is limited to synthetic patients and implementation-specific timing, and clinical use has not been validated. Adapters, pointer heads, and model cards are released on Hugging Face.

0.22

Locally Deployable Small Language Models for Emergency Department Decision Support: A Systematic Benchmark of Fine-Tuning Strategies

cs.CL cs.AI ·2026-08-10 ·Qingfeng Zhang, Yuanxiong Guo, Yanmin Gong
publishedbenchmarkcode/data similarity 0.63
Abstract · Accepted to AMIA 2026 Annual Symposium

Deploying large language models (LLMs) for decision support in emergency departments (EDs) faces two major challenges: privacy risks of transmitting patient data to closed-source commercial LLMs and the lack of systematic evaluation of fine-tuning strategies for locally deployable open-source small language models (SLMs). We benchmarked eight open-source SLMs using zero-shot prompting, prefix tuning, Low-Rank Adaptation (LoRA), and full fine-tuning on three ED tasks: triage level prediction, specialist referral recommendation, and diagnosis prediction. Using 2,083 MIMIC-IV-ED cases and Claude Haiku 4.5 and Claude Sonnet 4.5 as baselines, we found that LoRA fine-tuned open-source SLMs outperform commercial baselines on triage level prediction and specialist referral recommendation, while diagnosis prediction remains challenging for open-source SLMs. Confusion matrix analysis further shows that fine-tuned open-source SLMs can detect highest-severity patients missed by the commercial baselines. These results demonstrate that locally deployable SLMs can achieve clinically competitive performance for ED decision support.

0.35

Lightweight Machine Learning for Classifying Disaster-Related Social Media Posts

cs.NI cs.LG ·2026-10-17 ·Chengjun Jiang, Milena Radenkovic
similarity 0.63
Abstract

Classifying disaster-related social-media posts into humanitarian information labels is challenging because individual messages are typically short and context-limited, humanitarian categories can overlap semantically, and the CrisisBench label distribution is strongly imbalanced. This study investigates whether lightweight lexical machine-learning methods can provide effective and computationally efficient classification under these conditions. Using the CrisisBench v1.0 English humanitarian task, comprising 87,455 records across predefined Train, Development and Test splits, we conduct a controlled comparison of TF-IDF representations and lightweight classifiers, with Macro-F1 as the primary model-selection metric. Beyond aggregate predictive performance, the study jointly examines per-label behaviour, directional error patterns, relative decision margins, computational requirements, and the effect of domain-specific training through a tropical-cyclone specialist model. The selected balanced LinearSVC with unigram-bigram TF-IDF and C=0.5 achieved an Accuracy of 0.8282, a Macro-F1 of 0.6578 and a Weighted-F1 of 0.8315 on the held-out Test split. Lower decision margins were substantially associated with prediction errors, while the tropical-cyclone specialist achieved modestly higher in-domain aggregate performance with substantially lower feature and fitting requirements. The study contributes a controlled, label-sensitive and resource-aware evaluation of lightweight humanitarian text classification that characterises not only aggregate performance, but also where these models fail and how their behaviour changes under domain-specific training.

0.23

Advancing Clinical Trial Outcome Prediction with Domain-Specific Large Language Models

cs.AI ·2026-10-30 ·Burak Bakkar, Hana Moalla, Mohamed Salem Jedidi, Haifa Ben Messaoud, Nicolas Lopez Carranza
benchmark similarity 0.63
Abstract

Clinical trial failures are a major barrier to efficient drug development, incurring substantial costs and delaying patient access to effective therapies. Structured approaches such as the Hierarchical Interaction Network (HINT) predict trial outcomes by explicitly modelling interactions between drugs, diseases and protocols, but make limited use of the free text in trial registrations. We evaluate two domain-specific language models, BioBERT (108M parameters) and BioMistral (7B parameters), for phase-level outcome prediction on the TOP benchmark (12,477 trials), representing each trial as text built from ten ClinicalTrials.gov fields. We compare fine-tuning (full fine-tuning for BioBERT, low-rank adaptation for BioMistral) with probing, in which the pretrained model is frozen and only a lightweight classifier is trained on its embeddings. On the held-out test set of each phase, all four language-model variants achieved higher ROC-AUC (0.613--0.772) and PR-AUC (0.649--0.901) than the published HINT results, corresponding to relative PR-AUC gains of 10--20\%. F1 differences were small and mixed, and no model, including HINT, clearly exceeded the F1 of a trivial classifier that predicts success for every trial. Under the configurations tested, probing performed comparably to fine-tuning: fine-tuned models scored highest on ROC-AUC and PR-AUC in Phases I and II, and frozen BioMistral embeddings in Phase III (ROC-AUC 0.772; PR-AUC 0.901), although most differences between variants were below 0.03 and were not tested for significance. These results suggest that pretrained biomedical representations already encode signal relevant to trial outcome, and that probing is a computationally cheaper alternative to fine-tuning for this task.

0.22

Fine-Tuned Small Language Model for Synthetic Clinical Data Generation and Predictive Healthcare Analytics

cs.AI ·2026-11-12 ·Mihnea Sebastian Burlacu, Ionut Anghel, Tudor Cioara
similarity 0.62
Abstract

The reduced availability of medical datasets represents an important challenge in the development of predictive models for remote healthcare solutions, especially when the available data are imbalanced or difficult to extend through traditional methods. Small Language Models (SLMs) have become a promising alternative to Large Language Models (LLMs) for addressing these limitations due to their lower computational requirements and adaptability to specialized tasks. However, their performance remains highly dependent on the quality and representativeness of the available training data. In this paper, we propose a method for clinical data augmentation based on a fine-tuned Microsoft Phi-2 model that is used to generate synthetic instances, with the purpose of improving deep learning-based model for predicting remotely monitored vital signs. The Phi-2 model was adapted to the medical domain through supervised fine-tuning on the MedQuad dataset, through a Quantized Low-Rank Adaptation (QLoRA)-based method and by applying few-shot prompting techniques. The resulting model was used afterwards in the augmentation of a small-sized dataset, composed of vital sign values and labels associated with pathological and physiological states. The experimental results demonstrate that fine-tuned SLMs improved the performance on medical domain, achieving higher scores for both lexical (ROUGE) and semantic (BERTScore) evaluation metrics compared to the pretrained model. Moreover, the fine-tuned SLM is effective for generating structured synthetic clinical data. When used for data augmentation, the generated dataset improved the performance of a LSTM predictive model, increasing the classification accuracy from 89.0% to 93.7% and showing consistent improvements in precision, recall, and F1-score.

0.26

Detecting Unreliable Classifications from Quantized Models

cs.CV ·2026-10-13 ·Ananya Kotla, Jorge T. Gomez
hot direction similarity 0.62
Abstract · 1 figure, 5 tables

Post-training INT8 quantization is typically validated by checking accuracy retention, which requires ground-truth labels often unavailable in low-resource clinical settings. We show a label-free alternative: comparing a model's own output before and after quantization. We compute cosine similarity between the FP32 and INT8 models' output probability vectors for each prediction, which requires only a single forward pass. This output-agreement similarity separates lower-accuracy predictions across four evaluated architectures (ResNet-50, VGG-16-BN, Wide ResNet-50, and ViT-B/16) under fixed-percentile splits, outperforming a confidence-only baseline for all four. These results show that quantized models can be compared to their baselines to assess their drift and determine whether they are well suited for clinical deployment.

0.31